Scam alert related to banks
The following is issued on behalf of the Hong Kong Monetary Authority:
The Hong Kong Monetary Authority (HKMA) wishes to alert members of the public to the press releases issued by the banks listed below relating to fraudulent websites, internet banking login screens, phishing emails or other scams, which have been reported to the HKMA. Hyperlinks to the press releases are available on the HKMA website.
Bank
Type of scam
The Bank of East Asia, Limited
Fraudulent websites and internet banking login screens
Shanghai Commercial Bank Limited
Fraudulent website and internet banking login screen
OCBC Bank (Hong Kong) Limited
Fraudulent website and internet banking login screen
Industrial Bank Co., Ltd.
Fraudulent website
Chong Hing Bank Limited
Fraudulent website and internet banking login screen
The HKMA wishes to remind the public that banks will not send SMS or emails with embedded hyperlinks which direct them to the banks' websites to carry out transactions. They will not ask customers for sensitive information, such as login passwords or one-time password, by phone, email or SMS (including via embedded hyperlinks).
Anyone who has provided his or her personal information, or who has conducted any financial transactions, through or in response to the scams concerned, should contact the relevant bank with the information provided in the corresponding press release, and report the matter to the Crime Wing Information Centre of the Hong Kong Police Force at 2860 5012.
HKMA, Photo source: reference image
New York ETO promotes Hong Kong's life sciences and health innovation in Philadelphia
The Hong Kong Economic and Trade Office in New York (New York ETO) hosted a business forum and spring reception on March 12 (Philadelphia time) in Philadelphia, one of the most significant life science clusters in the United States, to promote Hong Kong's expanding role as a global hub for health and life sciences innovation and to explore opportunities for cross-border collaboration. Over 130 business leaders, investors, and innovators from across Greater Philadelphia gathered to learn more about Hong Kong's role as an international life and health science hub.
As part of the Economic and Trade Express initiative, the business forum was co-organised by the New York ETO, Invest Hong Kong, and the Hong Kong Trade Development Council (HKTDC), strengthening efforts in trade and investment promotion, and reinforcing Hong Kong's role as a "super connector" and "super value-adder".
In her welcome remarks, the Director of the New York ETO, Ms Maisie Ho, highlighted Hong Kong's remarkable progress in life sciences and healthcare, emphasising the latest measures to propel Hong Kong's life sciences and health technology ecosystem through a multipronged approach.
She elaborated on Hong Kong's integrated development plan, including reforming the evaluation regime for drugs and medical devices, promoting the use of real-world data to facilitate clinical research, setting up dedicated institutes and academies for research and clinical trials at the Hetao Shenzhen-Hong Kong Science and Technology Innovation Co-operation Zone in the Northern Metropolis, as well as dedicated efforts in attracting strategic enterprises, with a view to further strengthening Hong Kong's position as a leading health and innovation node.
Ms Ho added that Hong Kong's well-established financial ecosystem continues to play a pivotal role in supporting this growth. "Hong Kong ranks as the world's second-largest biotech fundraising hub, supporting a diverse range of innovative companies," she said.
The business forum featured two keynote presentations connecting life sciences and health innovation between Philadelphia and Hong Kong. In her keynote presentation, the Head of Business and Talent Attraction/Investment Promotion of the Invest Hong Kong in New York, Ms Yi Xie, highlighted Hong Kong as a launchpad for life sciences, showcasing its well- developed research and development infrastructure, robust intellectual property protection, and strategic gateway to the Guangdong–Hong Kong–Macao Greater Bay Area and Asia-Pacific markets. Meanwhile, the Director (New York & Midwest) of the HKTDC, Mr Curtis Louie, shared the range of support the HKTDC provides to Philadelphia companies, including matchmaking services for companies, and encouraged delegation participation in the upcoming Asia Summit on Global Health.
The presentations were then followed by a panel discussion moderated by the President and Chief Executive Officer of the Science History Institute, Dr David Cole, featuring the Founder and Chief Executive Officer of the ConSynance Therapeutics, Dr Liu Shuang; the Head of Global Business Development of the Jecho Laboratories, Dr Sarah Johnson; and the Director, Deal Advisory, US-China Corridor of KPMG, Mr Jon Hung. The speakers discussed collaboration, fundraising, clinical development, and market expansion in Asia.
On the same evening, Ms Ho hosted a spring reception for guests from the city's political, business, financial, and academic communities.
New York ETO promotes Hong Kong's life sciences and health innovation in Philadelphia Source: HKSAR Government Press Releases
New York ETO promotes Hong Kong's life sciences and health innovation in Philadelphia Source: HKSAR Government Press Releases
New York ETO promotes Hong Kong's life sciences and health innovation in Philadelphia Source: HKSAR Government Press Releases
New York ETO promotes Hong Kong's life sciences and health innovation in Philadelphia Source: HKSAR Government Press Releases
New York ETO promotes Hong Kong's life sciences and health innovation in Philadelphia Source: HKSAR Government Press Releases
New York ETO promotes Hong Kong's life sciences and health innovation in Philadelphia Source: HKSAR Government Press Releases
New York ETO promotes Hong Kong's life sciences and health innovation in Philadelphia Source: HKSAR Government Press Releases
New York ETO promotes Hong Kong's life sciences and health innovation in Philadelphia Source: HKSAR Government Press Releases
